Sangamo Therapeutics, Inc. (SGMO)
OTCMKTS · Delayed Price · Currency is USD
0.1851
+0.010785 (6.19%)
At close: May 26, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $76.68 million as of May 27, 2026. Its market cap has decreased by -52.22% in one year.
Market Cap
76.68M
Enterprise Value
68.43M
Revenue
34.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 76.68M, a decrease of -16.98%. That is a compound annual growth rate of -0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 76.68M | -45.74% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 156.02M |
| Glorywin Entertainment Group | 149.60M |
| HST Global | 117.39M |
| NDT Pharmaceuticals | 111.73M |
| BioStem Technologies | 70.12M |
| Cell Source | 55.72M |
| ProText Mobility | 55.38M |
| Nuo Therapeutics | 53.58M |